InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the detailed record of transactions filed by Wolf Myles, 董事. Insider active across 1 company, notably Akebia Therapeutics, Inc.. Cumulatively, 6 filings have been recorded. History available since 2 June 2021. The latest transaction was disclosed on 10 June 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Wolf Myles
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
35,700 股Common StockSEC:0001808317-26-000001:0
35,700 股0Common StockSEC:0001562180-25-004722:0
30,000 股0Common StockSEC:0001562180-24-004910:0
30,000 股0Common StockSEC:0001562180-23-004957:0
13,700 股0Common StockSEC:0001562180-22-004978:0
13,700 股0Common StockSEC:0001562180-21-004031:0
6 条申报中的 6 条
About Wolf Myles
Myles Wolf is a Board Member at Akebia Therapeutics, Inc. He contributes to the governance of the company by participating in strategic decisions and providing his expertise to the board.
